カテゴリ： 世界, 医療/バイオ, QYResearch

ベッカー筋ジストロフィーの世界市場2023年：内科的治療、手術治療

■ 英語タイトル：Global Becker Muscular Dystropy Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7426）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7426
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ベッカー筋ジストロフィーの世界市場2023年：内科的治療、手術治療]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はベッカー筋ジストロフィーのグローバル市場について調査・分析し、世界のベッカー筋ジストロフィー市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（内科的治療、手術治療）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Italfarmaco Spa、Milo Biotechnology Llc、Ptc Therapeutics Inc、Reveragen Biopharma Inc、Sarepta Therapeutics Incなどが含まれています。ベッカー筋ジストロフィーのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ベッカー筋ジストロフィー市場規模を算出する際に考慮しました。

・ベッカー筋ジストロフィー市場の概要
- ベッカー筋ジストロフィーの種類別セグメント
- 世界のベッカー筋ジストロフィー市場規模：タイプ別分析（内科的治療、手術治療）
- ベッカー筋ジストロフィーの用途別セグメント
- 世界のベッカー筋ジストロフィー市場規模：用途別分析（病院、診療所、その他）
- 世界のベッカー筋ジストロフィー市場規模予測（2018年-2029年）

・ベッカー筋ジストロフィー市場の成長トレンド
- ベッカー筋ジストロフィーの地域別市場規模（2018年-2029年）
- ベッカー筋ジストロフィー市場ダイナミクス
- ベッカー筋ジストロフィーの業界動向
- ベッカー筋ジストロフィー市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：内科的治療、手術治療
- 世界のベッカー筋ジストロフィーのタイプ別市場規模（2018年-2023年）
- 世界のベッカー筋ジストロフィーのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界のベッカー筋ジストロフィーの用途別市場規模（2018年-2023年）
- 世界のベッカー筋ジストロフィーの用途別市場規模（2024年-2029年）

・ベッカー筋ジストロフィーの地域別市場規模
- 北米のベッカー筋ジストロフィー市場規模（2018年-2029年）
- 米国のベッカー筋ジストロフィー市場規模（2018年-2029年）
- ヨーロッパのベッカー筋ジストロフィー市場規模（2018年-2029年）
- アジア太平洋のベッカー筋ジストロフィー市場規模（2018年-2029年）
- 中国のベッカー筋ジストロフィー市場規模（2018年-2029年）
- 日本のベッカー筋ジストロフィー市場規模（2018年-2029年）
- 韓国のベッカー筋ジストロフィー市場規模（2018年-2029年）
- インドのベッカー筋ジストロフィー市場規模（2018年-2029年）
- オーストラリアのベッカー筋ジストロフィー市場規模（2018年-2029年）
- 中南米のベッカー筋ジストロフィー市場規模（2018年-2029年）
- 中東・アフリカのベッカー筋ジストロフィー市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Italfarmaco Spa、Milo Biotechnology Llc、Ptc Therapeutics Inc、Reveragen Biopharma Inc、Sarepta Therapeutics Inc

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Becker Muscular Dystropy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Becker Muscular Dystropy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Becker Muscular Dystropy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Becker Muscular Dystropy in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Becker Muscular Dystropy include Italfarmaco Spa, Milo Biotechnology Llc, Ptc Therapeutics Inc, Reveragen Biopharma Inc and Sarepta Therapeutics Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Becker Muscular Dystropy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Becker Muscular Dystropy.
The Becker Muscular Dystropy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Becker Muscular Dystropy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Becker Muscular Dystropy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Italfarmaco Spa
Milo Biotechnology Llc
Ptc Therapeutics Inc
Reveragen Biopharma Inc
Sarepta Therapeutics Inc
Segment by Type
Medical Treatement
Operation Treatment
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Becker Muscular Dystropy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Becker Muscular Dystropy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Medical Treatement
1.2.3 Operation Treatment
1.3 Market by Application
1.3.1 Global Becker Muscular Dystropy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Becker Muscular Dystropy Market Perspective (2018-2029)
2.2 Becker Muscular Dystropy Growth Trends by Region
2.2.1 Global Becker Muscular Dystropy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Becker Muscular Dystropy Historic Market Size by Region (2018-2023)
2.2.3 Becker Muscular Dystropy Forecasted Market Size by Region (2024-2029)
2.3 Becker Muscular Dystropy Market Dynamics
2.3.1 Becker Muscular Dystropy Industry Trends
2.3.2 Becker Muscular Dystropy Market Drivers
2.3.3 Becker Muscular Dystropy Market Challenges
2.3.4 Becker Muscular Dystropy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Becker Muscular Dystropy Players by Revenue
3.1.1 Global Top Becker Muscular Dystropy Players by Revenue (2018-2023)
3.1.2 Global Becker Muscular Dystropy Revenue Market Share by Players (2018-2023)
3.2 Global Becker Muscular Dystropy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Becker Muscular Dystropy Revenue
3.4 Global Becker Muscular Dystropy Market Concentration Ratio
3.4.1 Global Becker Muscular Dystropy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Becker Muscular Dystropy Revenue in 2022
3.5 Becker Muscular Dystropy Key Players Head office and Area Served
3.6 Key Players Becker Muscular Dystropy Product Solution and Service
3.7 Date of Enter into Becker Muscular Dystropy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Becker Muscular Dystropy Breakdown Data by Type
4.1 Global Becker Muscular Dystropy Historic Market Size by Type (2018-2023)
4.2 Global Becker Muscular Dystropy Forecasted Market Size by Type (2024-2029)
5 Becker Muscular Dystropy Breakdown Data by Application
5.1 Global Becker Muscular Dystropy Historic Market Size by Application (2018-2023)
5.2 Global Becker Muscular Dystropy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Becker Muscular Dystropy Market Size (2018-2029)
6.2 North America Becker Muscular Dystropy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Becker Muscular Dystropy Market Size by Country (2018-2023)
6.4 North America Becker Muscular Dystropy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Becker Muscular Dystropy Market Size (2018-2029)
7.2 Europe Becker Muscular Dystropy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Becker Muscular Dystropy Market Size by Country (2018-2023)
7.4 Europe Becker Muscular Dystropy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Becker Muscular Dystropy Market Size (2018-2029)
8.2 Asia-Pacific Becker Muscular Dystropy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Becker Muscular Dystropy Market Size by Region (2018-2023)
8.4 Asia-Pacific Becker Muscular Dystropy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Becker Muscular Dystropy Market Size (2018-2029)
9.2 Latin America Becker Muscular Dystropy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Becker Muscular Dystropy Market Size by Country (2018-2023)
9.4 Latin America Becker Muscular Dystropy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Becker Muscular Dystropy Market Size (2018-2029)
10.2 Middle East & Africa Becker Muscular Dystropy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Becker Muscular Dystropy Market Size by Country (2018-2023)
10.4 Middle East & Africa Becker Muscular Dystropy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Italfarmaco Spa
11.1.1 Italfarmaco Spa Company Detail
11.1.2 Italfarmaco Spa Business Overview
11.1.3 Italfarmaco Spa Becker Muscular Dystropy Introduction
11.1.4 Italfarmaco Spa Revenue in Becker Muscular Dystropy Business (2018-2023)
11.1.5 Italfarmaco Spa Recent Development
11.2 Milo Biotechnology Llc
11.2.1 Milo Biotechnology Llc Company Detail
11.2.2 Milo Biotechnology Llc Business Overview
11.2.3 Milo Biotechnology Llc Becker Muscular Dystropy Introduction
11.2.4 Milo Biotechnology Llc Revenue in Becker Muscular Dystropy Business (2018-2023)
11.2.5 Milo Biotechnology Llc Recent Development
11.3 Ptc Therapeutics Inc
11.3.1 Ptc Therapeutics Inc Company Detail
11.3.2 Ptc Therapeutics Inc Business Overview
11.3.3 Ptc Therapeutics Inc Becker Muscular Dystropy Introduction
11.3.4 Ptc Therapeutics Inc Revenue in Becker Muscular Dystropy Business (2018-2023)
11.3.5 Ptc Therapeutics Inc Recent Development
11.4 Reveragen Biopharma Inc
11.4.1 Reveragen Biopharma Inc Company Detail
11.4.2 Reveragen Biopharma Inc Business Overview
11.4.3 Reveragen Biopharma Inc Becker Muscular Dystropy Introduction
11.4.4 Reveragen Biopharma Inc Revenue in Becker Muscular Dystropy Business (2018-2023)
11.4.5 Reveragen Biopharma Inc Recent Development
11.5 Sarepta Therapeutics Inc
11.5.1 Sarepta Therapeutics Inc Company Detail
11.5.2 Sarepta Therapeutics Inc Business Overview
11.5.3 Sarepta Therapeutics Inc Becker Muscular Dystropy Introduction
11.5.4 Sarepta Therapeutics Inc Revenue in Becker Muscular Dystropy Business (2018-2023)
11.5.5 Sarepta Therapeutics Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Becker Muscular Dystropy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Medical Treatement
Table 3. Key Players of Operation Treatment
Table 4. Global Becker Muscular Dystropy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Becker Muscular Dystropy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Becker Muscular Dystropy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Becker Muscular Dystropy Market Share by Region (2018-2023)
Table 8. Global Becker Muscular Dystropy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Becker Muscular Dystropy Market Share by Region (2024-2029)
Table 10. Becker Muscular Dystropy Market Trends
Table 11. Becker Muscular Dystropy Market Drivers
Table 12. Becker Muscular Dystropy Market Challenges
Table 13. Becker Muscular Dystropy Market Restraints
Table 14. Global Becker Muscular Dystropy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Becker Muscular Dystropy Market Share by Players (2018-2023)
Table 16. Global Top Becker Muscular Dystropy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Becker Muscular Dystropy as of 2022)
Table 17. Ranking of Global Top Becker Muscular Dystropy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Becker Muscular Dystropy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Becker Muscular Dystropy Product Solution and Service
Table 21. Date of Enter into Becker Muscular Dystropy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Becker Muscular Dystropy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Becker Muscular Dystropy Revenue Market Share by Type (2018-2023)
Table 25. Global Becker Muscular Dystropy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Becker Muscular Dystropy Revenue Market Share by Type (2024-2029)
Table 27. Global Becker Muscular Dystropy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Becker Muscular Dystropy Revenue Market Share by Application (2018-2023)
Table 29. Global Becker Muscular Dystropy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Becker Muscular Dystropy Revenue Market Share by Application (2024-2029)
Table 31. North America Becker Muscular Dystropy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Becker Muscular Dystropy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Becker Muscular Dystropy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Becker Muscular Dystropy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Becker Muscular Dystropy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Becker Muscular Dystropy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Becker Muscular Dystropy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Becker Muscular Dystropy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Becker Muscular Dystropy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Becker Muscular Dystropy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Becker Muscular Dystropy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Becker Muscular Dystropy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Becker Muscular Dystropy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Becker Muscular Dystropy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Becker Muscular Dystropy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Italfarmaco Spa Company Detail
Table 47. Italfarmaco Spa Business Overview
Table 48. Italfarmaco Spa Becker Muscular Dystropy Product
Table 49. Italfarmaco Spa Revenue in Becker Muscular Dystropy Business (2018-2023) & (US$ Million)
Table 50. Italfarmaco Spa Recent Development
Table 51. Milo Biotechnology Llc Company Detail
Table 52. Milo Biotechnology Llc Business Overview
Table 53. Milo Biotechnology Llc Becker Muscular Dystropy Product
Table 54. Milo Biotechnology Llc Revenue in Becker Muscular Dystropy Business (2018-2023) & (US$ Million)
Table 55. Milo Biotechnology Llc Recent Development
Table 56. Ptc Therapeutics Inc Company Detail
Table 57. Ptc Therapeutics Inc Business Overview
Table 58. Ptc Therapeutics Inc Becker Muscular Dystropy Product
Table 59. Ptc Therapeutics Inc Revenue in Becker Muscular Dystropy Business (2018-2023) & (US$ Million)
Table 60. Ptc Therapeutics Inc Recent Development
Table 61. Reveragen Biopharma Inc Company Detail
Table 62. Reveragen Biopharma Inc Business Overview
Table 63. Reveragen Biopharma Inc Becker Muscular Dystropy Product
Table 64. Reveragen Biopharma Inc Revenue in Becker Muscular Dystropy Business (2018-2023) & (US$ Million)
Table 65. Reveragen Biopharma Inc Recent Development
Table 66. Sarepta Therapeutics Inc Company Detail
Table 67. Sarepta Therapeutics Inc Business Overview
Table 68. Sarepta Therapeutics Inc Becker Muscular Dystropy Product
Table 69. Sarepta Therapeutics Inc Revenue in Becker Muscular Dystropy Business (2018-2023) & (US$ Million)
Table 70. Sarepta Therapeutics Inc Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Becker Muscular Dystropy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Becker Muscular Dystropy Market Share by Type: 2022 VS 2029
Figure 3. Medical Treatement Features
Figure 4. Operation Treatment Features
Figure 5. Global Becker Muscular Dystropy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Becker Muscular Dystropy Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Becker Muscular Dystropy Report Years Considered
Figure 11. Global Becker Muscular Dystropy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Becker Muscular Dystropy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Becker Muscular Dystropy Market Share by Region: 2022 VS 2029
Figure 14. Global Becker Muscular Dystropy Market Share by Players in 2022
Figure 15. Global Top Becker Muscular Dystropy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Becker Muscular Dystropy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Becker Muscular Dystropy Revenue in 2022
Figure 17. North America Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Becker Muscular Dystropy Market Share by Country (2018-2029)
Figure 19. United States Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Becker Muscular Dystropy Market Share by Country (2018-2029)
Figure 23. Germany Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Becker Muscular Dystropy Market Share by Region (2018-2029)
Figure 31. China Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Becker Muscular Dystropy Market Share by Country (2018-2029)
Figure 39. Mexico Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Becker Muscular Dystropy Market Share by Country (2018-2029)
Figure 43. Turkey Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Becker Muscular Dystropy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Italfarmaco Spa Revenue Growth Rate in Becker Muscular Dystropy Business (2018-2023)
Figure 46. Milo Biotechnology Llc Revenue Growth Rate in Becker Muscular Dystropy Business (2018-2023)
Figure 47. Ptc Therapeutics Inc Revenue Growth Rate in Becker Muscular Dystropy Business (2018-2023)
Figure 48. Reveragen Biopharma Inc Revenue Growth Rate in Becker Muscular Dystropy Business (2018-2023)
Figure 49. Sarepta Therapeutics Inc Revenue Growth Rate in Becker Muscular Dystropy Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 静脈逆流症治療の世界市場2023年：手術治療、非外科的治療
  • 各種肝硬変治療サービスのグローバル市場展望 2023年-2029年：手術治療、内科治療
  • 脊髄性筋萎縮症治療のグローバル市場（2022年-2029年）：ヌシネルセン、オナセムノゲンアベパルボベク
  • サケ中毒治療薬の世界市場2023年：経口、注射
  • 非筋層浸潤性膀胱がん治療薬の世界市場2023年：膀胱内化学療法、膀胱内免疫療法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7426 )"ベッカー筋ジストロフィーの世界市場2023年：内科的治療、手術治療" (英文：Global Becker Muscular Dystropy Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。